# ARYMO ER
> **NDA208603** · New Drug Application · Sponsor: ZYLA · Approved 2017-01-09
## Drug
- **FDA Application Number:** NDA208603
- **Application type:** New Drug Application
- **Brand name:** ARYMO ER
- **Generic name:** Morphine Sulfate
- **Active ingredients:** MORPHINE SULFATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ZYLA
- **First approval:** 2017-01-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208603)
---
*AI Analytics · CC0 1.0*